STOCK TITAN

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) will present at the Sidoti January Virtual Investor Conference on January 17-18, 2024. CEO Larry Jasinski and CFO Mike Lawless will provide an overview presentation and host one-on-one meetings with investors. Interested investors can register for the presentation or one-on-ones at www.sidoti.com/events.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the Sidoti January Virtual Investor Conference, taking place on January 17-18, 2024.

The presentation will begin at 2:30 PM EST on January 17, 2024 and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_ZpcK-ahiRLabYaQ5ySQKsw. ReWalk will also host virtual one-on-ones with investors on Wednesday and Thursday, January 17-18, 2023. Registration is available to interested investors for the presentation or one-on-ones at www.sidoti.com/events. Registration is free and interested investors do not need to be a Sidoti client.

About ReWalk Robotics Ltd.:

ReWalk Robotics Ltd. is a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions. ReWalk’s mission is to fundamentally change the quality of life for these individuals through the creation and development of market leading technologies. Through its recent acquisition of AlterG, Inc., ReWalk has added anti-gravity systems to its growing portfolio of products. Founded in 2001, ReWalk has operations in the United States, Israel, and Germany. For more information on the ReWalk systems, please visit rewalk.com. For more information on the AlterG systems, please visit alterg.com.

ReWalk® and ReStore® are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions. AlterG® is a registered trademark of AlterG, Inc. in the United States and other jurisdictions.

ReWalk Investor Contact:
Michael Lawless
Chief Financial Officer
ReWalk Robotics Ltd.
E: investorrelations@rewalk.com 

ReWalk Media Relations:
LifeSci Communications
E: media@rewalk.com 


FAQ

When is ReWalk Robotics Ltd. presenting at the Sidoti January Virtual Investor Conference?

ReWalk Robotics Ltd. (Nasdaq: RWLK) will present at the Sidoti January Virtual Investor Conference on January 17-18, 2024.

Who will provide an overview presentation at the conference?

CEO Larry Jasinski and CFO Mike Lawless will provide an overview presentation at the Sidoti January Virtual Investor Conference.

How can investors access the presentation live?

The presentation will begin at 2:30 PM EST on January 17, 2024 and can be accessed live at https://sidoti.zoom.us/webinar/register/WN_ZpcK-ahiRLabYaQ5ySQKsw.

How can interested investors register for the presentation or one-on-ones?

Interested investors can register for the presentation or one-on-ones at www.sidoti.com/events. Registration is free and open to all interested investors.

ReWalk Robotics Ltd.

NASDAQ:RWLK

RWLK Rankings

RWLK Latest News

RWLK Stock Data

8.92M
58.82M
1.96%
20.72%
2.27%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
P O Box 161

About RWLK

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the